New patent expiration for Ucb Inc drug NEUPRO

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for NEUPRO
Annual Drug Patent Expirations for NEUPRO

Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

NEUPRO drug price trends.

Drug patent litigation for NEUPRO.

This drug has one hundred and forty-three patent family members in thirty-eight countries.

The generic ingredient in NEUPRO is rotigotine. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top